Covered recipient · General Payments record
DOUGLAS C BREWER
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,720.75
- Reported across 220 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $559.65 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $194.85 | 15 |
| Corcept Therapeutics | $160.55 | 9 |
| Novo Nordisk AS | $101.57 | 5 |
| Lilly USA, LLC | $40.89 | 2 |
| RECORDATI_RARE_DISEASES_INC. | $23.49 | 1 |
| Acerta Pharma LLC | $19.51 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $19.98 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117209790 | CMS |
| Amgen Inc. | $10.02 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117209792 | CMS |
| Amgen Inc. | $6.75 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117209794 | CMS |
| Amgen Inc. | $5.57 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117209796 | CMS |
| Amgen Inc. | $4.94 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117209798 | CMS |
| Amgen Inc. | $18.45 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117209800 | CMS |
| Amgen Inc. | $6.06 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117209802 | CMS |
| Amgen Inc. | $8.55 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117209804 | CMS |
| Amgen Inc. | $18.89 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117209806 | CMS |
| Amgen Inc. | $8.32 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117209808 | CMS |
| Amgen Inc. | $7.23 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117209810 | CMS |
| Amgen Inc. | $30.18 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111536283 | CMS |
| Amgen Inc. | $30.18 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111536285 | CMS |
| Amgen Inc. | $12.64 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117209812 | CMS |
| Amgen Inc. | $7.09 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117209814 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.51 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105796744 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.79 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118007071 | CMS |
| Corcept Therapeutics | $20.15 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117792442 | CMS |
| Corcept Therapeutics | $22.07 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117792490 | CMS |
| Corcept Therapeutics | $17.68 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117792512 | CMS |
| Corcept Therapeutics | $3.24 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117792550 | CMS |
| Corcept Therapeutics | $21.92 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117792552 | CMS |
| Corcept Therapeutics | $4.50 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117792558 | CMS |
| Corcept Therapeutics | $25.06 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117792568 | CMS |
| Corcept Therapeutics | $14.04 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117792570 | CMS |
| Corcept Therapeutics | $31.89 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117792584 | CMS |
| Lilly USA, LLC | $18.29 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136148938 | CMS |
| Lilly USA, LLC | $22.60 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136162467 | CMS |
| Novo Nordisk Inc | $13.37 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096811790 | CMS |
| Novo Nordisk Inc | $20.79 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096658006 | CMS |
| Novo Nordisk Inc | $19.50 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097011207 | CMS |
| Novo Nordisk Inc | $23.32 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097368402 | CMS |
| Novo Nordisk Inc | $24.59 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097198425 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $23.49 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139161548 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.